Did Family Ties Allow Mylan CEO to Perform EpiPen Price Gouging

by KJ McElrath | Sep 24, 2016 | Pharmaceutical Industry |

In a meeting of the House Oversight Committee this week, U.S. Representative Tammy Duckworth...

Antibiotic Resistant “Superbugs”: is Big Pharma Responsible?

by KJ McElrath | Sep 22, 2016 | Pharmaceutical Industry |

A shocking publication from the European Public Health Alliance in collaboration with the UK...

FDA Approves Drug That Doesn’t Work; BUT Big Pharma Will Make $2 Billion On It

by Farron Cousins | Sep 20, 2016 | Pharmaceutical Industry |

FDA Chief Dr. Robert Califf approved a muscular dystrophy drug this week against the findings of...

Big Pharma Price Gouging: What’s REALLY Going On

by KJ McElrath | Sep 19, 2016 | Pharmaceutical Industry |

Over the weekend, activists stood outside the offices of Mylan Pharmaceuticals chanting, “Heather...

Clinton Proposes Ideas to Stop Price Gouging on Life-Saving Drugs

by KJ McElrath | Sep 11, 2016 | Pharmaceutical Industry |

Over the past decade, Mylan raised the price of the EpiPen, a life-saving device for people with...

Unbranded Advertising: Is Big Pharma Going Too Far?

by KJ McElrath | Aug 30, 2016 | Pharmaceutical Industry |

The pharmaceutical industry is becoming increasingly unpopular with the American public – and...